EMA: Draft GL for OIPs [BE/BA News]

posted by Helmut Homepage – Vienna, Austria, 2024-04-19 17:40 (144 d 00:43 ago) – Posting: # 23959
Views: 2,201

Dear all,

as a birthday gift the EMA published a

Draft guideline on the requirements for demonstrating therapeutic equivalence between orraly inhaled products (OIP) for asthma and chronic obstructive pulmonary disease (COPD).

Consultation is open until 30 October 2024.
—
Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,223 posts in 4,877 threads, 1,657 registered users;
31 visitors (0 registered, 31 guests [including 8 identified bots]).
Forum time: 18:23 CEST (Europe/Vienna)

Explanations exist; they have existed for all time;
there is always an easy solution to every human problem –
neat, plausible and wrong.    H. L. Mencken

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5